TransEnterix Senhance Microlaparoscopy 3 mm Instruments Portfolio Receives 2019 Innovations of the Year Award From SLS
The Senhance® Surgical System with digital laparoscopy is the first robotic platform to integrate 3 mm instrumentation, minimizing invasiveness to improve the patient experience. The comprehensive microlaparoscopy 3 mm instruments portfolio provides performance similar to traditional 5 mm instruments, with the benefits of robotic precision, advanced control and a digital interface that eliminates many of the usability challenges of traditional handheld 3 mm instruments. The integration of a 3 mm instruments portfolio is designed to allow surgeons to use smaller ports, with as much as a 70% reduction in port size compared to typical 5 mm trocars, which may lead to virtually scarless procedures and better cosmesis.
“We thank the SLS for two consecutive years of recognizing the technological improvements the Senhance System brings to the market,” said
During MISWeek 2019,
This press release includes forward looking statements. These statements and other statements regarding our future plans and goals constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations. For a discussion of the risks and uncertainties associated with
Mark Klausner, +1 443-213-0501
Joanna Rice, + 1 951-751-1858